Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0001209191-23-052622

Director sold 242 shares at $360.00 ($87,120)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bhatia Sangeeta N. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-10-06 Sale : show line 1 in the form 10b5-1 −242 $360.00 $87,120 4,144 D
Open-market sales · 242 sh · avg $360.00 · $87,120
Loading xslF345X05/doc4.xml…